1.
Linagliptin is associated to increased treatment adherence and satisfaction in elderly outpatients with diabetes and advanced chronic kidney disease. Geriatr Care [Internet]. 2016 Nov. 10 [cited 2026 May 7];2(3). Available from: https://www.pagepressjournals.org/gc/article/view/6220